New Zealand markets close in 6 hours

BDX Jan 2025 360.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.90000.0000 (0.00%)
As of 03:35PM EDT. Market open.
Full screen
Previous close1.9000
Open1.9000
Bid0.0000
Ask1.7000
Strike360.00
Expiry date2025-01-17
Day's range1.9000 - 1.9000
Contract rangeN/A
Volume1
Open interest6
  • Zacks

    BD's (BDX) FDA-Approved Test to Offer Wider Testing Access

    BD's (BDX) receipt of the FDA's clearance for the use of self-collected vaginal specimens for HPV testing is likely to improve screening access to a wider female population.

  • PR Newswire

    Women in U.S. Can Now Collect Their Own Sample for Cervical Cancer Screening

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) approval for the use of self-collected vaginal specimens for human papillomavirus (HPV) testing when cervical specimens cannot otherwise be obtained. The approval allows women to self-collect vaginal specimens for HPV testing in a health care setting, which could include non-traditional locations such as a retail pharmacy or mobile clinic.

  • Insider Monkey

    11 Best Recession Dividend Stocks To Buy

    In this article, we discuss 11 best recession dividend stocks to buy. You can skip our detailed analysis of dividend stocks and their past performance during recessionary periods, and go directly to read 5 Best Recession Dividend Stocks To Buy. Several financial analysts, previously forecasting a recession in the US at the end of 2022, […]